GlobalRPh Renal Dosing Masterv6.6
GlobalRPh source record

Lisinopril

READ THE SOURCE-SPECIFIC ANSWER

Renal guidance at a glance

Cautions / source differences (1)
Review first - source-specific qualification

Before use: Lisinopril

Starting doses agree in selected sections; clinical context still controls titration.

Before applying: Distinguish initial dosing from maintenance; confirm formulation, indication, blood pressure, potassium and interacting medicines.

Evidence for this qualification

Source-specific interpretation; independent clinician adjudication pending.

Confirm the product, indication and renal measure. The selected summary is not a complete prescribing monograph.

Choose a source to read (3)

Display order is not a clinical ranking. Date of retrieval is not the label revision date. Sources are never merged into one regimen. Other sources and conflicts remain below.

Official source

Lisinopril - conventional oral tablets

Product / population
Adults; conventional oral lisinopril tablets, indication-specific starting doses.
Renal measure
Creatinine clearance, mL/min

Renal guidance and important limits

Limits that apply to these rows

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

Adult renal starting-dose instruction
CrCl, mL/minSource-specific dose / instruction
>30No renal-specific adjustment
10-30 (inclusive)Half usual starting dose: hypertension 5 mg; systolic heart failure 2.5 mg; acute MI 2.5 mg
<10 or hemodialysis2.5 mg once daily
Read the retained text before reformatting

Adult renal starting-dose instruction

CrCl, mL/minSource-specific dose / instruction
>30No renal-specific adjustment
10-30 (inclusive)Half usual starting dose: hypertension 5 mg; systolic heart failure 2.5 mg; acute MI 2.5 mg
<10 or hemodialysis2.5 mg once daily

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

Source revision: 9/2021 | Retrieved: 2026-09-10. Retrieval date is not the revision date.

Source: https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f20acd7-2635-4a9b-b732-2a84ea93dea7

Scope: Selected source sections stored locally. Not a complete monograph or independent clinical approval. GlobalRPh v6.6.

Full source card / provenance

All sources, comparison tools and evidence navigation
Source-specific interpretation

What the dialysis evidence actually supports

Removal information alone does not define a maintenance dose, supplemental dose or dialysis schedule. A reported regimen still requires its product, indication, renal measure and dialysis assumptions to match the patient.

Lisinopril - conventional oral tablets

Authored v6.3; retrieved 2026-09-10 - retained source, not freshly reviewed in this release

A dialysis-population initial dose is reported; maintenance requires titration

Read the source and its limits

GlobalRPh RX List - Zestril

Authored v6.3; retrieved 2026-09-10 - retained source, not freshly reviewed in this release

A dialysis-population initial dose is reported; maintenance requires titration

Read the source and its limits

These manual classifications apply only to the identified selected sections, not every retained source or the entire prescribing information. They are not dosing clearance.

Source-first renal review

Evidence sources and renal implications

Choose a source to jump directly to its locally stored result. Qualitative precautions and evidence gaps remain visible even when no numerical clearance schedule is supplied.

Read 1 source difference / applicability notes

Preserved GlobalRPh source

Preserved original GlobalRPh source

Preserved historical content; not revalidated as current prescribing guidance.

Renal method: Read the measure and population stated in the original source sections.
Retrieved: 2026-09-05

Official product label

Lisinopril - conventional oral tablets

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Distinguish initial dosing from maintenance; confirm formulation, indication, blood pressure, potassium and interacting medicines.

Dialysis evidence: A dialysis-population initial dose is reported; maintenance requires titration

Adults; conventional oral lisinopril tablets, indication-specific starting doses.

Renal method: Creatinine clearance, mL/min
Retrieved: 2026-09-10

GlobalRPh RX List

GlobalRPh RX List - Zestril

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Distinguish initial dosing from maintenance; confirm formulation, indication, blood pressure, potassium and interacting medicines.

Dialysis evidence: A dialysis-population initial dose is reported; maintenance requires titration

Adults; conventional oral lisinopril tablets, indication-specific starting doses.

Renal method: Creatinine clearance, mL/min
Retrieved: 2026-09-10

Source presence is not independent validation. A label mirror is not a second independent source; review the original reference and exact formulation.

Find text within this drug
Find a term without leaving this drug

Search the stored clinical text

Locate a word or phrase within this drug's source summaries. Choose all sources or one source to focus the search. The selection never hides warnings or source text, changes a dose, or proves that a renal finding is absent.

Find:

Enter at least two characters. Searches stay on this page and are not saved or sent.

All source summaries, original wording and provenance
Before applying a renal protocol

Check the setting. Compare whole sources.

No patient-specific dose is calculated. Context choices only display reminders; they do not validate, hide or change any regimen.

Share a reproducible source review

Choose sources below, then open a print-ready comparison with product scope, renal method, dates and cautions. Links can pin the exact local cards; they never contain patient values or choose a dose.

Open / share selected sources

Select two distinct source versions. The complete stored summaries will appear below.

Build a source-review outline for documentation

This creates a blank decision outline with the source identities you select, not a dose recommendation or completed clinical assessment. No patient fields are collected, saved or sent. Complete the clinical decisions in your approved documentation system.

Choose one or two sources above or use the source checkboxes below.

Renal-context checklist: population, kidney trend and dialysis

These prompts are a reading aid, not a prescription checklist or proof that all requirements have been met. No selections are stored or sent to a server.

Read the exact source scope, renal metric and date before selecting a row. No applicability assessment has been performed.

See source-specific renal methods and the clinical interpretation guide for the supporting context.

Read before choosing a regimen

Source differences and product cautions

Search differences across all drugs

These are specific issues found during source review, not an automated judgment that one source is universally correct. A label mirror and its original label are not independent evidence.

source scope and renal guidance

Before use: Lisinopril

Starting doses agree in selected sections; clinical context still controls titration.

How to use this: Distinguish initial dosing from maintenance; confirm formulation, indication, blood pressure, potassium and interacting medicines.

Source-specific interpretation; independent clinician adjudication pending.

Go directly to the relevant source section

Renal dosing and precautions

Choose a source, then jump to its renal or dialysis section. These links locate stored text; they do not merge regimens or certify that sources agree.

New source summary - independent clinical review pending. Summaries of the identified label sections are included locally. Source import and numeric transcription checks are not independent two-reference validation. Do not treat this card as an approved institutional dosing protocol.

No dialysis or renal heading shown? Read the complete source summary. Absence of a heading is not evidence that dose adjustment is unnecessary.

Compare or copy source versions

All content below is stored locally. Read a whole source version; do not combine its dose with another source's interval, renal metric or dialysis assumptions.

Choose two source checkboxes below.
Historical source content is not a current prescription. Original GlobalRPh recommendations are preserved, not automatically certified as current. Product-label and professional additions below are separately attributed. Confirm indication, population, kidney-function method, monitoring and the full prescribing information before applying a regimen.

Important source distinctions

The source contains a malformed comparison in its low-pressure myocardial-infarction initiation sentence. Do not use that sentence as an executable algorithm; consult current labeling.

Locally stored source content

Original GlobalRPh protocol

Clinical facts and comments transcribed into a structured reading format. This is not a byte-for-byte HTML archive. Original source: https://globalrph.com/renal/lisinopril/

Hypertension

Without diuretics: start 10 mg once daily; usual range 20-40 mg once daily. If the effect wears off, particularly at 10 mg, evaluate blood pressure immediately before dosing and consider increasing the dose. Doses of 80 mg were used without additional benefit. Adding low-dose hydrochlorothiazide, such as 12.5 mg, has an additive effect; the lisinopril dose may then be reduced.

Stop an existing diuretic 2-3 days before initiation when possible; resume if needed for blood-pressure control. If it cannot be stopped, start 5 mg and supervise for at least 2 hours and until blood pressure has remained stable for an additional hour. Potassium supplements, potassium-containing salt substitutes and potassium-sparing diuretics may raise serum potassium.

GRPH-lisinopril-01 · Source section: HypertensionRenal section finder

Heart failure

Adjunct to diuretics and usually digoxin: start 5 mg once daily under observation, especially with systolic pressure below 100 mmHg. The peak blood-pressure effect occurs at 6-8 hours. Observe until stable; reduce the diuretic if possible when hypovolemic. Initial hypotension does not preclude careful retitration after it is treated. Usual source range: 5-20 mg daily.

GRPH-lisinopril-02 · Source section: Heart failureRenal section finder

Acute myocardial infarction and older adults

For hemodynamically stable patients, initiate within 24 hours of symptoms: 5 mg initially, 5 mg after 24 hours, 10 mg after 48 hours, then 10 mg daily for 6 weeks, with usual thrombolytic, aspirin and beta-blocker treatment.

The low-pressure initiation sentence in the source is written as systolic pressure '=120 mmHg' at initiation or during the first 3 days, with a 2.5 mg dose. Its comparison operator is not reconstructed here.

If systolic pressure is at or below 100 mmHg, use 5 mg daily, temporarily reducing to 2.5 mg if needed. Withdraw for systolic pressure at or below 90 mmHg persisting more than 1 hour.

Older adults have similar blood-pressure responses but approximately double Cmax/AUC; use cautious dose adjustment.

GRPH-lisinopril-03 · Source section: Acute myocardial infarction and older adultsRenal section finder

Renal Dosing

Hypertension, CrCl in mL/min:

  • Above 30: usual initial 10 mg daily.
  • 10-30: initial 5 mg daily.
  • Below 10: initial 2.5 mg daily.

Titrate to blood-pressure response to a maximum of 40 mg daily in this renal table. The source associates the renal threshold with serum creatinine approximately 3 mg/dL and notes dialysis membrane-associated anaphylactoid reactions; interval and dose are determined by blood-pressure response.

Heart failure with sodium below 130 mEq/L, CrCl at or below 30, or serum creatinine above 3 mg/dL: begin 2.5 mg daily under close supervision.

Acute MI with serum creatinine above 2 mg/dL: use cautiously; severe-impairment adjustment was not studied in the source.

GRPH-lisinopril-04 · Source section: Renal DosingRenal section finder

Hemodialysis

See the renal table and membrane-associated anaphylactoid-reaction warning above.

GRPH-lisinopril-05 · Source section: HemodialysisRenal section finder
Separate U.S. product-label layer

FDA / DailyMed dosing and renal information

Official

Lisinopril - conventional oral tablets

Open original reference

Open / share this exact local source

DailyMed / NLM exact product labeling · Adults; conventional oral lisinopril tablets, indication-specific starting doses.

Renal method: Creatinine clearance, mL/min
Source date: 9/2021
Retrieved: 2026-09-10

Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Distinguish initial dosing from maintenance; confirm formulation, indication, blood pressure, potassium and interacting medicines.

Dialysis evidence: A dialysis-population initial dose is reported; maintenance requires titration

Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Renal guidance and important limits

Limits that apply to these rows

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

Adult renal starting-dose instruction
CrCl, mL/minSource-specific dose / instruction
>30No renal-specific adjustment
10-30 (inclusive)Half usual starting dose: hypertension 5 mg; systolic heart failure 2.5 mg; acute MI 2.5 mg
<10 or hemodialysis2.5 mg once daily
Read the retained text before reformatting

Adult renal starting-dose instruction

CrCl, mL/minSource-specific dose / instruction
>30No renal-specific adjustment
10-30 (inclusive)Half usual starting dose: hypertension 5 mg; systolic heart failure 2.5 mg; acute MI 2.5 mg
<10 or hemodialysis2.5 mg once daily

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

RDM63-official-lisinopril-d717d46070-C1 · Source locator: Dose in patients with renal impairment; official section 2.4; warnings 5.1-5.5

Source-specific limits

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

Source identity and provenance
Source family
product_label
Source
https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=8f20acd7-2635-4a9b-b732-2a84ea93dea7
Retrieved
2026-09-10
Exact label title
Lisinopril - conventional oral tablets
DailyMed Set ID
8f20acd7-2635-4a9b-b732-2a84ea93dea7
Label revision
9/2021
Renal-function method
Creatinine clearance, mL/min
Source date/version
9/2021
Hash meaning
Local authored summary, not source HTML/XML/PDF bytes
Local summary SHA-256
fe077fc4ffc55b1990a5bde30c59c93bf32dc66e16a33d843e20d359e9557ba2
Locally imported selected renal sections

GlobalRPh RX List renal information

Rxlist

GlobalRPh RX List - Zestril

Open original reference

Open / share this exact local source

GlobalRPh-hosted RX List · Adults; conventional oral lisinopril tablets, indication-specific starting doses.

Renal method: Creatinine clearance, mL/min
Source date: Revision not established in selected sections
Retrieved: 2026-09-10

Label mirror, not independent corroboration. This is selected locally stored RX List content. Full monograph import and current official-label review are not implied.
Dose or interval guidance. Use only the product, indication, renal metric and population described in this source.
Before using this finding

Distinguish initial dosing from maintenance; confirm formulation, indication, blood pressure, potassium and interacting medicines.

Dialysis evidence: A dialysis-population initial dose is reported; maintenance requires titration

Selected source sections stored locally. Not a complete monograph or independent clinical approval.

Renal guidance and important limits

Limits that apply to these rows

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

Adult renal starting-dose instruction
CrCl, mL/minSource-specific dose / instruction
>30No renal-specific adjustment
10-30 (inclusive)Half usual starting dose: hypertension 5 mg; systolic heart failure 2.5 mg; acute MI 2.5 mg
<10 or hemodialysis2.5 mg once daily
Read the retained text before reformatting

Adult renal starting-dose instruction

CrCl, mL/minSource-specific dose / instruction
>30No renal-specific adjustment
10-30 (inclusive)Half usual starting dose: hypertension 5 mg; systolic heart failure 2.5 mg; acute MI 2.5 mg
<10 or hemodialysis2.5 mg once daily

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

RDM63-rxlist-lisinopril-0422e4ebda-C1 · Source locator: Dose in patients with renal impairment; official section 2.4; warnings 5.1-5.5

Source-specific limits

This is an initiation table, not a maintenance-dose calculator. Titrate as tolerated; the renal section gives a 40 mg/day ceiling.

Monitor blood pressure, potassium and kidney function. Pregnancy/fetal toxicity, angioedema and interacting medicines remain separate restrictions.

Source identity and provenance
Source family
product_label_mirror
Source
https://globalrph.com/rx-list/zestril-drug/
Retrieved
2026-09-10
Renal-function method
Creatinine clearance, mL/min
Source date/version
Revision not established in selected sections
Hash meaning
Local authored summary, not source HTML/XML/PDF bytes
Local summary SHA-256
fe077fc4ffc55b1990a5bde30c59c93bf32dc66e16a33d843e20d359e9557ba2

Provenance and preservation

Additional summaries stored on this page: 1 official-label, 1 RX List, 0 professional, 0 handbook. Empty additional-source groups are not shown. A missing layer is not a no-adjustment recommendation.

Original source
https://globalrph.com/renal/lisinopril/
Source retrieval
2026-09-05. This is not the source publication or label revision date.
Original source type
globalrph individual
Local text SHA-256
41c5ec85e9331d28a12c3706d6f6aa51a2ce5d3e6da020c08e1001a32ec69d37
Import versus clinical validation
Source-section locators identify where retained content came from. A source-section identifier does not assert that every numeric statement has been independently corroborated. The local text hash is not a hash of original HTML, an FDA PDF or SPL XML.

The original individual GlobalRPh pages commonly cite NIH/NLM DailyMed and instruct readers to review the applicable package insert for updates. That historical reference is preserved as context; it is not counted as an independently retrieved current label.

Read the full coverage report